News: Front Section

Cusano of Cummings Properties signs enEvolv to 10,000 s/f lease

Medford, MA enEvolv, a biotechnology firm, will open a new and larger laboratory and research office. The 10,000 s/f space is located at 200 Boston Ave., a commercial building operated by Cummings Properties. It will replace enEvolv’s former facility on Morrissey Blvd. in Boston. 

“Boston Ave. is a great location for biotech firms because it’s close to research and academic institutions like Tufts and MIT,” said Cummings leasing officer Steve Cusano, who worked on the transaction with Ellen Cullinan of Freudenheim Partners. “In addition, it’s close enough to the city to offer public transportation and many area amenities, but client firms also benefit from free parking as well as leasing rates that are a third lower than those typically found in nearby Cambridge.”

Steve Cusano, Cummings Properties

 

Ellen Cullinan, Freudenheim Partners

 

“enEvolv is expanding, and this new location offers the company a larger first-class laboratory that it can grow into,” said Cullinan.

enEvolv joins other leaders in life sciences and technology that have offices within Cummings Properties’ Boston Ave.  portfolio, located near I-93 and Rtes. 2, 3, and 60.

Cummings Properties’ portfolio of 11 million s/f of prime space accommodates offices, healthcare facilities, labs, restaurants, retail storefronts, warehouses, co-working spaces, executive suites, and more. With a portfolio of this size and variety, the firm can meet almost any commercial real estate need from 150 square feet to 300,000 square feet. Its in-house experts in design, construction, and property management offer “one-stop shopping” for leasing clients.

enEvolv works with pharmaceutical, nutrition, energy, and specialty chemical companies to engineer microbes and produce bio-based chemicals. The company’s strain engineering platform combines biotechnology with automation to identify the changes in genomes that produce specific results, such as preventing genetically modified organisms from escaping and thriving in the wild. Its co-founder, renowned geneticist George Church, has appeared in media outlets from The Washington Post to “The Late Show with Stephen Colbert.”

MORE FROM Front Section
Front Section

McEvoy of The Conrad Group brokers $2.9 million sale of industrial building

Hingham, MA The Conrad Group  has brokered the sale of 55 Research Rd., South Shore Park. The property consists of a 20,340 s/f single story manufacturing building on two acres of land.
READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
Newmark negotiates sale of  10 Liberty Sq. and 12 Post Office Sq.

Newmark negotiates sale of 10 Liberty Sq. and 12 Post Office Sq.

Boston, MA Newmark has completed the sale of 10 Liberty Sq. and 12 Post Office Sq. Newmark co-head of U.S. Capital Markets Robert Griffin and Boston Capital Markets executive vice chairman Edward Maher, vice chairman Matthew Pullen, executive managing director James Tribble,
5 Questions to ask when  choosing a real estate broker - by Elizabeth Perez Barlett

5 Questions to ask when choosing a real estate broker - by Elizabeth Perez Barlett

>They say, “April showers bring May flowers,” but this season may bring more movement in the housing market as springtime is one of the most popular times for home buying and selling. Although spring is one of the strongest seasons for the residential market, it may not be all rosebuds and butterflies if you don’t have the right advisors.
It’s time to get creative with closed college campuses - by Christian Koulichkov

It’s time to get creative with closed college campuses - by Christian Koulichkov

Facing higher costs, shrinking enrollments, reduced state funding and severe demographic headwinds, many colleges and universities in New England and the Northeast are fighting for survival. The latest to lose the battle is the 150 + year old University of the Arts in
Investing in a falling rate environment - by Harrison Klein

Investing in a falling rate environment - by Harrison Klein

Long-term interest rates have fallen by 100 basis points, and the market is normalizing. In December of 2022 I wrote an article about investing in a high interest rate, high inflation market. Since then, inflation has cooled off, and the Fed has begun lowering their funds rate.